Royal Bank of Canada’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $787M | Sell |
5,647,122
-265,759
| -4% | -$37.2M | 0.14% | 142 |
|
|
2025
Q4 | $726M | Sell |
5,912,881
-1,414,795
| -19% | -$172M | 0.12% | 162 |
|
|
2025
Q3 | $813M | Buy |
7,327,676
+396,347
| +6% | +$45.1M | 0.13% | 144 |
|
|
2025
Q2 | $768M | Buy |
6,931,329
+748,027
| +12% | +$79.6M | 0.14% | 144 |
|
|
2025
Q1 | $693M | Sell |
6,183,302
-2,495,449
| -29% | -$257M | 0.14% | 140 |
|
|
2024
Q4 | $802M | Buy |
8,678,751
+2,005,863
| +30% | +$181M | 0.16% | 121 |
|
|
2024
Q3 | $559M | Buy |
6,672,888
+304,655
| +5% | +$23.2M | 0.11% | 164 |
|
|
2024
Q2 | $437M | Sell |
6,368,233
-761,687
| -11% | -$50.8M | 0.1% | 191 |
|
|
2024
Q1 | $522M | Sell |
7,129,920
-3,507,571
| -33% | -$270M | 0.12% | 158 |
|
|
2023
Q4 | $862M | Sell |
10,637,491
-189,734
| -2% | -$14.8M | 0.2% | 101 |
|
|
2023
Q3 | $811M | Sell |
10,827,225
-327,946
| -3% | -$25.2M | 0.22% | 91 |
|
|
2023
Q2 | $860M | Buy |
11,155,171
+910,264
| +9% | +$72.6M | 0.23% | 93 |
|
|
2023
Q1 | $850M | Sell |
10,244,907
-1,094,612
| -10% | -$90.7M | 0.24% | 87 |
|
|
2022
Q4 | $973M | Buy |
11,339,519
+1,437,260
| +15% | +$114M | 0.28% | 77 |
|
|
2022
Q3 | $611M | Buy |
9,902,259
+730,795
| +8% | +$46.1M | 0.19% | 102 |
|
|
2022
Q2 | $567M | Buy |
9,171,464
+1,141,771
| +14% | +$70.7M | 0.17% | 121 |
|
|
2022
Q1 | $477M | Buy |
8,029,693
+835,010
| +12% | +$53.4M | 0.12% | 158 |
|
|
2021
Q4 | $522M | Buy |
7,194,683
+475,162
| +7% | +$32.7M | 0.12% | 152 |
|
|
2021
Q3 | $469M | Sell |
6,719,521
-123,706
| -2% | -$8.69M | 0.12% | 155 |
|
|
2021
Q2 | $471M | Sell |
6,843,227
-57,743
| -0.8% | -$3.86M | 0.13% | 148 |
|
|
2021
Q1 | $446M | Buy |
6,900,970
+81,074
| +1% | +$5.23M | 0.13% | 147 |
|
|
2020
Q4 | $397M | Buy |
6,819,896
+144,285
| +2% | +$8.71M | 0.12% | 170 |
|
|
2020
Q3 | $422M | Buy |
6,675,611
+701,104
| +12% | +$48.6M | 0.15% | 142 |
|
|
2020
Q2 | $460M | Sell |
5,974,507
-44,591
| -0.7% | -$3.42M | 0.18% | 118 |
|
|
2020
Q1 | $450M | Buy |
6,019,098
+487,160
| +9% | +$33.7M | 0.22% | 97 |
|
|
2019
Q4 | $359M | Buy |
5,531,938
+1,667,635
| +43% | +$109M | 0.13% | 146 |
|
|
2019
Q3 | $245M | Buy |
3,864,303
+582,879
| +18% | +$38.1M | 0.1% | 184 |
|
|
2019
Q2 | $222M | Buy |
3,281,424
+1,119,906
| +52% | +$73.7M | 0.09% | 197 |
|
|
2019
Q1 | $141M | Sell |
2,161,518
-23,427
| -1% | -$1.56M | 0.06% | 270 |
|
|
2018
Q4 | $137M | Sell |
2,184,945
-406,885
| -16% | -$28.4M | 0.07% | 255 |
|
|
2018
Q3 | $201M | Sell |
2,591,830
-19,585
| -0.7% | -$1.48M | 0.08% | 198 |
|
|
2018
Q2 | $185M | Sell |
2,611,415
-699,981
| -21% | -$49.4M | 0.08% | 205 |
|
|
2018
Q1 | $250M | Buy |
3,311,396
+14,401
| +0.4% | +$1.14M | 0.11% | 155 |
|
|
2017
Q4 | $236M | Buy |
3,296,995
+58,489
| +2% | +$4.44M | 0.1% | 167 |
|
|
2017
Q3 | $262M | Sell |
3,238,506
-670,830
| -17% | -$51.3M | 0.13% | 140 |
|
|
2017
Q2 | $277M | Buy |
3,909,336
+725,985
| +23% | +$48.3M | 0.14% | 126 |
|
|
2017
Q1 | $216M | Sell |
3,183,351
-774,194
| -20% | -$54.4M | 0.12% | 140 |
|
|
2016
Q4 | $283M | Sell |
3,957,545
-947,496
| -19% | -$70.4M | 0.15% | 113 |
|
|
2016
Q3 | $388M | Sell |
4,905,041
-634,835
| -11% | -$51.6M | 0.22% | 80 |
|
|
2016
Q2 | $462M | Buy |
5,539,876
+264,923
| +5% | +$23.5M | 0.28% | 67 |
|
|
2016
Q1 | $485M | Sell |
5,274,953
-183,272
| -3% | -$16.5M | 0.3% | 57 |
|
|
2015
Q4 | $552M | Buy |
5,458,225
+1,095,947
| +25% | +$114M | 0.36% | 48 |
|
|
2015
Q3 | $428M | Buy |
4,362,278
+27,135
| +0.6% | +$3.01M | 0.32% | 52 |
|
|
2015
Q2 | $508M | Buy |
4,335,143
+1,338,692
| +45% | +$146M | 0.35% | 43 |
|
|
2015
Q1 | $294M | Sell |
2,996,451
-198,589
| -6% | -$20.2M | 0.21% | 74 |
|
|
2014
Q4 | $301M | Buy |
3,195,040
+475,440
| +17% | +$49.2M | 0.19% | 80 |
|
|
2014
Q3 | $290M | Buy |
2,719,600
+51,401
| +2% | +$5.03M | 0.2% | 80 |
|
|
2014
Q2 | $221M | Buy |
2,668,199
+212,143
| +9% | +$16.5M | 0.15% | 102 |
|
|
2014
Q1 | $174M | Sell |
2,456,056
-1,633,397
| -40% | -$128M | 0.13% | 114 |
|
|
2013
Q4 | $307M | Buy |
4,089,453
+57,414
| +1% | +$4M | 0.22% | 68 |
|
|
2013
Q3 | $253M | Buy |
4,032,039
+198,596
| +5% | +$11.9M | 0.19% | 73 |
|
|
2013
Q2 | $197M | Buy |
+3,833,443
| New | +$200M | 0.17% | 87 |
|
Other funds holding GILD
VCM
VPM
Royal Bank of Canada's GILD Position: Q1 2026 in Review
Royal Bank of Canada reduced its Gilead Sciences (GILD) stake by 4.5% in Q1 2026, selling an estimated $37.2M and leaving 5,647,122 shares worth $787M. The position accounts for 0.14% of the portfolio, ranked #142.
Royal Bank of Canada first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $973M in Q4 2022. 2,312 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Royal Bank of Canada held 5,647,122 shares of Gilead Sciences worth $787M as of Q1 2026.
- Royal Bank of Canada sold 265,759 Gilead Sciences shares in Q1 2026, an estimated $37.2M.
- Gilead Sciences made up 0.14% of Royal Bank of Canada's portfolio in Q1 2026, its #142 holding.
- Royal Bank of Canada first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's Gilead Sciences position peaked at $973M in Q4 2022.
- 2,312 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.